Masimo has obtained clearance from the FDA to market its O3 regional oximetry monitoring system with an O3 pediatric sensor, allowing it to be used in pediatric patients weighing less than 88 pounds and more than 11 pounds. The system, which has already been cleared for use in adults, enables continuous monitoring of cerebral oxygen saturation using near-infrared spectroscopy.
FDA clears Masimo's O3 regional oximetry device for pediatric use
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.